Effects of tachykinin receptor antagonists on leukotriene C4-induced bronchoconstriction and airway microvascular leakage in guinea pigs

Erqing Wei,Weiping Zhang,Z. Y. Lu,Rulian Bian
1997-01-01
Abstract:The involvement of endogenous tachykinins in the airway actions of leukotriene C4 (LTC4 ) was studied. LTC4 (0.5 ��g��kg-1, iv) increased intrapulmonary pressure (IPP) and extravasation of Evans blue in the airways in guinea pigs. CP-96345 {(2S,3S)-cis-2-(diphenylmethyl)-N-[(2-methoxyphenyl)-methyl]- 1-azabic yclo[2.2.2]octane-3-amine}, a NK-1 tachykinin receptor antagonist (1 mg��kg-1, iv) attenuated LTC4-induced increase of Evans blue extravasation in the airways, and SR-48968 {(S)-N-methyl-N-[4-(4-acetylamino-4-phenylpiperidino)-2-(3,4- dichloro phenyl) butyl] benzamide}, a NK-2 receptor antagonist (1 mg��kg-1, iv) inhibited increase in IPP, respectively. ONO-1078 (0.03 mg��kg-1, iv), a leukotriene antagonist, decreased both responses. The results indicate that endogenous tachykinins potentiate the responses of LTC4 on airways, microvascular leakage mediated by NK-1 receptors, and bronchoconstriction by NK-2 receptors.
What problem does this paper attempt to address?